Ionis Pharmaceuticals, Inc. (IONS)
73.78
-1.01
(-1.35%)
USD |
NASDAQ |
Apr 06, 14:44
Ionis Pharmaceuticals EPS Diluted (Quarterly) : -1.414 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | -0.3333 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Mirum Pharmaceuticals, Inc. | -0.111 |
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -229.00M |
| Revenue (Quarterly) | 203.00M |
| Total Expenses (Quarterly) | 432.00M |
| Enterprise Value | 12.29B |
| Gross Profit Margin (Quarterly) | 94.14% |
| Profit Margin (Quarterly) | -112.8% |
| Earnings Yield | -3.34% |
| Normalized Earnings Yield | -3.417 |